ESR1 and breast carcinoma: Previous studies have reported that in estrogen receptor α (ER)-positive (ER+) cells, androgens inhibit cell proliferation [6, 7], whereas in ER-negative (ER−) breast cancer cells, androgens activate cell proliferation [8].